The largest database of trusted experimental protocols

7 protocols using nrg1β1

1

Neuregulin 1 Isoform β1 Modulates SAH Pathology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Extracellular domain of Neuregulin 1 isoformβ1 (Nrg1β1, R&D systems, Minneapolis, MN, United States) was used for activation of ErbB4, and administered intraperitoneally at 1 h after SAH induction. Besides the sham and vehicle groups, two groups of rats received a different dosage of Nrg1β1 (50 ng/kg and 150 ng/kg, n = 6). The dose of Nrg1β1was set according to a previous study (Depboylu et al., 2015 (link)). For outcome evaluation, neurobehavioral scores, brain edema and albumin extravasation were measured at 24 and 72 h after SAH in all groups (n = 6). The expression levels of ErbB4, ErbB4 ICD, YAP, PIK3CB, Occludin and Claudin-5 were analyzed via Western blotting.
+ Open protocol
+ Expand
2

Quantitative Analysis of ERBB Family in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared in lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% IGEPAL CA-630) with protease inhibitors (Complete EDTA-free protease inhibitor tablets, Roche Applied Science, Inc., Indianapolis, IN, USA, cat. no. 11836170001) and phosphatase inhibitors (PhosSTOP, Roche Applied Science, Inc., cat. no. 4906845001). Samples were clarified by centrifugation in a microfuge at 4 degrees for 10 min. Samples were run on SDS-PAGE gels under reducing conditions and transferred to nitrocellulose. Blots were probed for ERBB1 (Santa Cruz, Inc., cat. no. sc-03), ERBB2 (Lab Vision, Inc., cat. no. MS-599-P1), ERBB3 (Santa Cruz, Inc., cat. no. sc-285), ERBB4 (Cell Signaling Technology, Inc., cat. no. 4795), RET (R&D Systems, Inc., cat. no. AF482), NRG1α1 (R&D Systems, Inc., cat. no. AF296NA), NRG1β1 (R&D Systems, Inc., cat. no. AF396NA), phospho-AKT-S473 (Cell Signaling Technology, Inc., cat. no. 9271), phospho-P42/44 MAPK (Cell Signaling Technology, Inc., cat. no. 9101) and alpha-tubulin (Biogenex, Inc., Fremont, CA, USA, cat. no. MU121-UC). Secondary antibodies labeled with IRDye 800CW or 680LT were from Li-Cor Biosciences, Inc. (Lincoln, NB, USA). Blots were imaged on Odyssey Classic Quantitative Fluorescence Imaging System, Model 9120, also from Li-Cor Biosciences.
+ Open protocol
+ Expand
3

Molecular Regulation of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HBEGF and NRG1β1 were from R&D Systems Inc. (Minneapolis, MN). Cell culture medium was from Sigma-Aldrich (St. Louis, MO). FBS was from Atlanta Biologicals, Inc. (Lawrenceville, GA). Ribogreen RNA quantification kit and Alexa-conjugated secondary antibodies were from Life TechnologiesTM (Grand Island, NY). YAP siRNAs were from Dhamarcon/Thermo Scientific (Pittsburgh, PA), HBEGF and ERBB3 siRNA were from Santa Cruz Biotechnology, Inc. (Dallas, Texas) and Life TechnologiesTM (supplementary Fig. S18). Antibodies against total and phosphorylated YAP, LATS1, MOB1, ErbBs, ATK and ER1/2 were from Cell Signaling Technology Inc. (Danvers, MA).
+ Open protocol
+ Expand
4

Generation of Cardiomyocytes from Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEFs or TTFs were seeded onto six-well plates (coated with 1:100 Matrigel from BD Biosciences for 1 h at room temperature) at a density of 50 000 cells per well and cultured in fibroblast growth medium. After 24 h, the medium was replaced with CRM plus various compound combinations, such as CRFVPT. CRM is composed of knockout DMEM (Gibco), 15% FBS, and 5% KSR (Gibco), 0.5% N2 (Gibco), 2% B27 (Gibco), 1% Glutamax, 1% NEAA, 0.1 mM β-mercaptoethanol (Gibco), 50 μg/ml 2-phospho-L-ascorbic acid (vitamin C, Sigma), 100 units/ml penicillin and 100 μg/ml streptomycin. CRFVPT cocktail consists of 10 μM CHIR99021 (C); 10 μM RepSox (R); 50 μM Forskolin (F); 0.5 mM VPA (V); 5 μM Parnate, (P); 1 μM TTNPB (T). CRM containing chemical compounds was changed every 4 days. At the second stage of induction (day 16 for MEF, day 20 for TTF), cells were cultured in CMM for various days. CMM is composed of DMEM medium with 15% FBS, 2i (3 μM CHIR99021 and 1 μM PD0325901), 1 000 units/ml LIF, 50 μg/ml vitamin C, and 1 μg/ml insulin (Sigma). The following growth factors were also tested in CMM for the generation of TTF-derived CiCMs: Tβ-4 (100 ng/ml, PeproTech), GDF-11 (100 ng/ml, PeproTech), G-CSF (20 ng/ml, R&D systems), NRG1-β1 (100 ng/ml, R&D systems).
+ Open protocol
+ Expand
5

Quantitative Immunoblotting of RTKs and Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysates were prepared in lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% IGEPAL CA-630) with protease inhibitors (Complete EDTA-free protease inhibitor tablets, Roche Applied Science, Inc, Indianapolis, IN, USA, cat # 11836170001), and phosphatase inhibitors (PhosSTOP, Roche Applied Science, Inc, cat # 4906845001). Samples were clarified by centrifugation in a microfuge at 4 degrees for 10 minutes. Samples were run on SDS PAGE gels under reducing conditions and transferred to nitrocellulose. Blots were probed for ERBB1 (Santa Cruz, Inc, cat no. sc-03), ERBB2 (Lab Vision, Inc, cat no. MS-599-P1), ERBB3 (Santa Cruz, Inc, cat no. sc-285), ERBB4 (Cell Signaling Technology, Inc, cat no. 4795), RET (R&D Systems, Inc, cat no. AF482), NRG1α1 (R&D Systems, Inc, cat no. AF296NA), NRG1β1 (R&D Systems, Inc, cat no. AF396NA), phospho-AKT-S473 (Cell Signaling Technology, Inc, cat no. 9271), phospho-P42/44 MAPK (Cell Signaling Technology, Inc, cat no. 9101), and alpha-tubulin (Biogenex, Inc, Fremont, CA, USA, cat no. MU121-UC). Secondary antibodies labeled with IRDye 800CW or 680LT were from Li-Cor Biosciences, Inc. (Lincoln, NB, USA). Blots were imaged on Odyssey Classic Quantitative Fluorescence Imaging System, Model 9120, also from Li-Cor Biosciences.
+ Open protocol
+ Expand
6

Schwann Cell Isolation from Rat Sciatic Nerve

Check if the same lab product or an alternative is used in the 5 most similar protocols
To harvest Schwann cells (SC), rat sciatic nerves were exposed, removed, and kept in DMEM plus glutamax (Invitrogen, UK) containing 100 U/mL penicillin and 100 μg/mL streptomycin. Nerves were then dissected in trunks, desheathed, and finally chopped in 1 mm segments. The segments were then plated in a Petri dish in SC growth medium (DMEM plus glutamax containing 100 U/mL penicillin, 100 μg/mL streptomycin, 14 μM forskolin, and 100 ng/mL NRG1β1, R&D Systems, UK). Cells were incubated for 2 weeks at 37°C with fresh medium added approximately every 72 h. After these 2 weeks medium was aspirated and 0.125% (w/v) collagenase type IV and 117 U/mg dispase were added to the Petri dish. After 24 hours (h) incubation, cell suspension was filtered through a 70 mm cell strainer (Falcon; BD Biosciences Discovery Labware, Bedford, MA) and centrifuged at 100 ×g for 5 min to obtain the cell pellet. Finally, the cell pellet was resuspended in SC growth medium, seeded into a Petri dish pre-coated with poly-D-lysine (Sigma, St Louis, MO, USA), and incubated in the same conditions. The following day, the medium was changed and cells were left to proliferate. When confluent, SC were purified by an antibody complement method to eradicate the remaining fibroblasts [14 (link)–16 (link)].
+ Open protocol
+ Expand
7

Neuroprotective Effects of NRG1-β1 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ninety male C57BL/6 mice with the age of 14-month old were purchased from the Animal Center of Jinling Hospital, Nanjing, China. The mice were housed five per cage in a 12-h light/dark cycle in a room of 22 ± 1 °C with food and water available ad libitum. After 7 days of accommodation, the mice were randomly divided into five groups (n = 18): control group, dimethyl sulfoxide (vehicle) group, isoflurane group, isoflurane + NRG1-β1 (a recombinant NRG1-1β; R&D Systems, Minneapolis, MN) group, and isoflurane + NRG1-β1 + AG1478 (an ErbB4 inhibitor; Tocris Bioscience, Bristol, United Kingdom) group.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!